Inhaled Corticosteroid Device Market, by Types of Steroid Inhalers (Beclomethasone Dipropionate, Budesonide, Fluticasone, Mometasone, and Others), by Application (Asthma, COPD, and Others), by End-Users (Hospitals and Others) – Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Inhaler Corticosteroid Device Market, by Types

6.1 Introduction

6.2 Beclomethasone Dipropionate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Budesonide

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Fluticasone Inhaler Powder

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Mometasone

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Inhaler Corticosteroid Device Market, by Applications

7.1 Introduction

7.2 Asthma

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 COPD (Chronic Obstructive Pulmonary Disease)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Inhaler Corticosteroid Device Market, by End-Users

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Respiratory Care Center

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Inhaler Corticosteroid Device Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Plumage Therapeutics LLP

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Pearl Therapeutic Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Teijin LTD

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Glaxo’s Advair

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11. 5 LIYEN, Inc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Amgen Inc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Kos Pharmaceutical, Inc

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Teva Pharmaceutical

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Inhaler Corticosteroid Device Market Synopsis, 2020-2027

Table 2 Global Inhaler Corticosteroid Device Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Inhaler Corticosteroid Device Market, by Region, 2020-2027 (USD Million)

Table 4 Global Inhaler Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 5 Global Inhaler Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 6 North America: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 7 North America: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 8 US: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 9 US: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 10 Canada: Inhaled Corticosteroid Device Market, By Types, 2020-2027 (USD Million)

Table 11 Canada: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 12 South America: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 13 South America: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 14 Europe: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 15 Europe: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 16 Western Europe: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 17 Western Europe: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 18 Eastern Europe: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 19 Eastern Europe: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 20 Asia-Pacific: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 21 Asia-Pacific: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

Table 22 Middle East & Africa: Inhaled Corticosteroid Device Market, by Types, 2020-2027 (USD Million)

Table 23 Middle East & Africa: Inhaled Corticosteroid Device Market, by End-Users, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Inhaler Corticosteroid Device Market

Figure 3 Segmentation Market Dynamics for Global Inhaler Corticosteroid Device Market

Figure 4 Global Inhaler Corticosteroid Device Market Share, By Types, 2020

Figure 5 Global Inhaler Corticosteroid Device Market Share, By End-Users, 2020

Figure 6 Global Inhaler Corticosteroid Device Market Share, By Region, 2020

Figure 7 North America: Global Inhaler Corticosteroid Device Market Share, By Country, 2020

Figure 8 Europe: Global Inhaler Corticosteroid Device Market Share, By Country, 2020

Figure 9 Asia-Pacific: Global Inhaler Corticosteroid Device Market Share, By Country, 2020

Figure 9 Middle East & Africa: Global Inhaler Corticosteroid Device Market Share, By Country, 2020

Figure 10 Global Inhaler Corticosteroid Device Market: Company Share Analysis, 2020 (%)

Figure 11 Plumage Therapeutics LLP: Key Financials

Figure 12 Plumage Therapeutics LLP: Segmental Revenue

Figure 14 Plumage Therapeutics LLP: Geographical Revenue

Figure 15 Pearl Therapeutic Inc.: Key Financials

Figure 16 Pearl Therapeutic Inc.: Segmental Revenue

Figure 17 Pearl Therapeutic Inc.: Geographical Revenue

Figure 18 Teijin LTD: Key Financials

Figure 19 Teijin LTD: Segmental Revenue

Figure 20 Teijin LTD: Geographical Revenue

Figure 21 Glaxo’s Advair: Key Financials

Figure 22 Glaxo’s Advair: Segmental Revenue

Figure 23 Glaxo’s Advair: Geographical Revenue

Figure 24 LIYEN, Inc: Key Financials

Figure 25 LIYEN, Inc: Segmental Revenue

Figure 26 LIYEN, Inc: Geographical Revenue

Figure 27 Amgen Inc: Key Financials

Figure 28 Amgen Inc :Segmental Revenue

Figure 29 Amgen Inc :Geographical Revenue

Figure 30 Kos Pharmaceutical, Inc: Key Financials

Figure 31 Kos Pharmaceutical, Inc: Segmental Revenue

Figure 32 Kos Pharmaceutical, Inc: Geographical Revenue

Figure 33 Teva Pharmaceutical: Key Financials

Figure 34 Teva Pharmaceutical: Segmental Revenue

Figure 35 Teva Pharmaceutical: Geographical Revenue